Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Return on Equity (2023 - 2025)

CG Oncology's Return on Equity history spans 3 years, with the latest figure at 0.22% for Q4 2025.

  • For Q4 2025, Return on Equity fell 8.0% year-over-year to 0.22%; the TTM value through Dec 2025 reached 0.22%, down 8.0%, while the annual FY2025 figure was 0.22%, 7.0% up from the prior year.
  • Return on Equity reached 0.22% in Q4 2025 per CGON's latest filing, roughly flat from 0.22% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.42% in Q4 2023 to a low of 0.25% in Q1 2024.
  • Average Return on Equity over 3 years is 0.11%, with a median of 0.15% recorded in 2025.
  • Peak YoY movement for Return on Equity: tumbled -56bps in 2024, then grew 11bps in 2025.
  • A 3-year view of Return on Equity shows it stood at 0.42% in 2023, then crashed by -133bps to 0.14% in 2024, then plummeted by -61bps to 0.22% in 2025.
  • Per Business Quant, the three most recent readings for CGON's Return on Equity are 0.22% (Q4 2025), 0.22% (Q3 2025), and 0.19% (Q2 2025).